Loading
An early trial studying the safety and activity of experimental treatment. Its registry status does not establish patient benefit.
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial). ClinicalTrials.gov record last updated 2026-09-04: recruiting. Enrollment is planned at 500 participants. Primary completion is estimated at 2028-03-31. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/